Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $52.9 million.

  • Praxis Precision Medicines' Total Liabilities rose 5743.67% to $52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 5743.67%. This contributed to the annual value of $37.7 million for FY2024, which is 10602.88% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Total Liabilities stood at $52.9 million for Q3 2025, which was up 5743.67% from $48.6 million recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Total Liabilities high stood at $52.9 million for Q3 2025, and its period low was $18.3 million during Q4 2023.
  • For the 4-year period, Praxis Precision Medicines' Total Liabilities averaged around $34.4 million, with its median value being $33.9 million (2023).
  • As far as peak fluctuations go, Praxis Precision Medicines' Total Liabilities plummeted by 5315.72% in 2023, and later soared by 12131.77% in 2025.
  • Over the past 4 years, Praxis Precision Medicines' Total Liabilities (Quarter) stood at $39.0 million in 2022, then tumbled by 53.16% to $18.3 million in 2023, then skyrocketed by 106.03% to $37.7 million in 2024, then surged by 40.42% to $52.9 million in 2025.
  • Its Total Liabilities stands at $52.9 million for Q3 2025, versus $48.6 million for Q2 2025 and $39.5 million for Q1 2025.